title: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
abstract: The capacity of HIV-1 to establish latent infection of CD4+ T cells may allow viral persistence despite immune responses and antiretroviral therapy. Measurements of infectious virus and viral RNA in plasma and of infectious virus, viral DNA and viral messenger RNA species in infected cells all suggest that HIV-1 replication continues throughout the course of infection. Uncertainty remains over what fraction of CD4+ T cells are infected and whether there are latent reservoirs for the virus. We show here that during the asymptomatic phase of infection there is an extremely low total body load of latently infected resting CD4+ T cells with replication-competent integrated provirus (<10(7) cells). The most prevalent form of HIV-1 DNA in resting and activated CD4+ T cells is a full-length, linear, unintegrated form that is not replication competent. The infection progresses even though at any given time in the lymphoid tissues integrated HIV-1 DNA is present in only a minute fraction of the susceptible populations, including resting and activated CD4+ T cells and macrophages.
authors.affiliation: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
authors.forename: T W
authors.initials: TW
authors.lastname: Chun
authors.forename: L
authors.initials: L
authors.lastname: Carruth
authors.forename: D
authors.initials: D
authors.lastname: Finzi
authors.forename: X
authors.initials: X
authors.lastname: Shen
authors.forename: J A
authors.initials: JA
authors.lastname: DiGiuseppe
authors.forename: H
authors.initials: H
authors.lastname: Taylor
authors.forename: M
authors.initials: M
authors.lastname: Hermankova
authors.forename: K
authors.initials: K
authors.lastname: Chadwick
authors.forename: J
authors.initials: J
authors.lastname: Margolick
authors.forename: T C
authors.initials: TC
authors.lastname: Quinn
authors.forename: Y H
authors.initials: YH
authors.lastname: Kuo
authors.forename: R
authors.initials: R
authors.lastname: Brookmeyer
authors.forename: M A
authors.initials: MA
authors.lastname: Zeiger
authors.forename: P
authors.initials: P
authors.lastname: Barditch-Crovo
authors.forename: R F
authors.initials: RF
authors.lastname: Siliciano
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000821:virology*; D002478:Cells, Cultured; D018920:Coculture Techniques; D004279:DNA, Viral / Q000032:analysis; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology / Q000821:virology*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D007156:Immunologic Memory; D017493:Leukocyte Common Antigens / Q000032:analysis; D008198:Lymph Nodes / Q000821:virology*; D008213:Lymphocyte Activation; D008264:Macrophages / Q000821:virology; D016133:Polymerase Chain Reaction; D011533:Proviruses / Q000502:physiology; D019562:Viral Load; D016662:Virus Integration; D017735:Virus Latency; D014779:Virus Replication
chemical_list: D019380:Anti-HIV Agents; D004279:DNA, Viral; D017493:Leukocyte Common Antigens